Dialysis therapies: a National Dialogue.
The National Institute of Diabetes, Digestive, and Kidney Diseases-supported Kidney Research National Dialogue asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Kidney Research National Dialogue participants identified the need to improve outcomes in ESRD by decreasing mortality and morbidity and enhancing quality of life as high priority areas in kidney research. To reach these goals, we must identify retained toxins in kidney disease, accelerate technologic advances in dialysate composition and devices to remove these toxins, advance vascular access, and identify measures that decrease the burden of disease in maintenance dialysis patients. Together, these research objectives provide a path forward for improving patient-centered outcomes in ESRD.
Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington;, †Ohio State University, Columbus, Ohio;, ‡University Health Network, Toronto, Ontario, Canada;, §University of California, San Francisco, California;, ‖Oregon Health and Science University, Portland, Oregon;, ¶Emory University, Atlanta, Georgia, *National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland.
Rajnish
R
Mehrotra
Anil
A
Agarwal
Joanne M
JM
Bargman
Jonathan
J
Himmelfarb
Kirsten L
KL
Johansen
Suzanne
S
Watnick
Jack
J
Work
Kevin
K
McBryde
Michael
M
Flessner
Paul L
PL
Kimmel
D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D018579:Patient Selection; D018802:Patient-Centered Care; D058996:Quality Improvement; D019984:Quality Indicators, Health Care; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods / Q000401:mortality / Q000592:standards; D012307:Risk Factors; D016896:Treatment Outcome